Why do patients with heart failure suffer from erectile dysfunction? A critical review and suggestions on how to approach this problem

No abstract is available for this paper.

• Publication year

  2005

• Venue

  International journal of impotence research

• Publication date

  2005-12-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/sj.ijir.3901426PMID 16391540
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sexual activity and the post coronary patient.

  2019cited by this paper
• Sexual Dysfunction in Male Patients with Hypertension

  2012cited by this paper
• Pharmacosexology update: prescription drugs and sexual function.

  2012cited by this paper
• The relationship between lipid profile and erectile dysfunction

  2007cited by this paper
• Erectile dysfunction.

  2006cited by this paper
• Efficacy and safety of sildenafil citrate in men with erectile dysfunction and chronic heart failure.

  2005cited by this paper
• Kein Einfluß von Digitalis auf Sexual-und Nebennierenrindenhormone bei gesunden Probanden und bei Patienten mit Herzinsuffizienz

  2005cited by this paper
• Association between smoking and erectile dysfunction: a population-based study.

  2005cited by this paper
• Effect of Lifestyle Changes on Erectile Dysfunction in Obese Men. A Randomized Controlled Trial

  2005cited by this paper
• Obesity, the metabolic syndrome, and sexual dysfunction

  2005cited by this paper
• The relationship between lipid profile and erectile dysfunction

  2005cited by this paper
• Relationship between metabolic syndrome and erectile dysfunction.

  2004cited by this paper
• Improvement in erectile function in men with organic erectile dysfunction by correction of elevated cholesterol levels: a clinical observation.

  2004cited by this paper
• Use of sildenafil for safe improvement of erectile function and quality of life in men with New York Heart Association classes II and III congestive heart failure: a prospective, placebo-controlled, double-blind crossover trial.

  2004cited by this paper
• Penile revascularization surgery for arteriogenic erectile dysfunction: the long‐term efficacy rate calculated by survival analysis

  2004cited by this paper
• Cardiovascular effects of the 3 phosphodiesterase-5 inhibitors approved for the treatment of erectile dysfunction.

  2004cited by this paper
• Gene therapy techniques for the delivery of endothelial nitric oxide synthase to the corpora cavernosa for erectile dysfunction.

  2004cited by this paper
• Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial.

  2004cited by this paper
• Prevalence and risk factors of erectile dysfunction in three cities of China: a community-based study.

  2004cited by this paper
• Prevalence and risk factors of erectile dysfunction in Japanese men with type 2 diabetes.

  2004cited by this paper
• The 45-year story of the development of an anti-aldosterone more specific than spironolactone.

  2004cited by this paper
• The prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction.

  2004cited by this paper
• Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease.

  2003cited by this paper
• Sexual Function in Men Older Than 50 Years of Age: Results from the Health Professionals Follow-up Study

  2003cited by this paper
• Prevalence and risk factors for erectile dysfunction in a population-based study in Iran

  2003cited by this paper
• The effects of replacing dihydropyridine calcium‐channel blockers with angiotensin II receptor blocker on the quality of life of hypertensive patients

  2003cited by this paper
• Erectile dysfunction in the cardiac patient: how common and should we treat?

  2003cited by this paper
• Report of erectile dysfunction after therapy with beta-blockers is related to patient knowledge of side effects and is reversed by placebo.

  2003cited by this paper
• Sustained efficacy and tolerability of vardenafil, a highly potent selective phosphodiesterase type 5 inhibitor, in men with erectile dysfunction: results of a randomized, double-blind, 26-week placebo-controlled pivotal trial.

  2003cited by this paper
• Effect of the angiotensin II antagonist valsartan on sexual function in hypertensive men

  2003cited by this paper
• Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial.

  2003cited by this paper
• ERECTILE DYSFUNCTION: CARDIOVASCULAR RISK AND THE ROLE OF THE CARDIOLOGIST

  2003cited by this paper
• Relation of erectile dysfunction to angiographic coronary artery disease.

  2003cited by this paper
• Prevalence and severity of erectile dysfunction in 50 to 75-year-old Finnish men.

  2003cited by this paper
• Prevalence of erectile dysfunction in Colombia, Ecuador, and Venezuela: a population-based study (DENSA)

  2002cited by this paper
• Change in quality of life in patients with permanent cardiac pacemakers: a six-month follow-up study.

  2002cited by this paper
• Cigarette smoking as risk factor for erectile dysfunction: results from an Italian epidemiological study.

  2002cited by this paper
• Sildenafil for male erectile dysfunction: a systematic review and meta-analysis.

  2002cited by this paper
• Prevalencia de disfunción eréctil en pacientes con hipertensión arterial

  2002cited by this paper
• [Prevalence erectile dysfunction in patients with hypertension].

  2002cited by this paper
• Sildenafil Effects on Exercise, Neurohormonal Activation, and Erectile Dysfunction in Congestive Heart Failure: A Double-Blind, Placebo-Controlled, Randomized Study Followed by a Prospective Treatment for Erectile Dysfunction

  2002cited by this paper
• Intracavernosal injection of vascular endothelial growth factor induces nitric oxide synthase isoforms

  2002cited by this paper
• IC351 (tadalafil, Cialis): update on clinical experience

  2002cited by this paper
• Prevalence and determinants of erectile dysfunction in Santos, southeastern Brazil

  2002cited by this paper
• RhoA/Rho-kinase: a novel player in the regulation of penile erection

  2001cited by this paper
• Effects of beta-blockers on sexual performance in men with coronary heart disease. A prospective, randomized and double blinded study

  2001cited by this paper
• The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial

  2001cited by this paper
• Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study.

  2001cited by this paper
• Systemic and cavernous plasma levels of endothelin (1–21) during different penile conditions in healthy males and patients with erectile dysfunction

  2001cited by this paper
• Prevalence of and risk factors for erectile dysfunction in Hong Kong diabetic patients

  2001cited by this paper
• Systemic and cavernosal plasma levels of endothelin (1-21) during different penile conditions in healthy males and patients with erectile dysfunction.

  2001cited by this paper
• Vardenafil increases penile rigidity and tumescence in erectile dysfunction patients: a RigiScan and pharmacokinetic study

  2001cited by this paper
• Changes in notions about heart failure.

  2001cited by this paper
• Drug Therapy and Prevalence of Erectile Dysfunction in the Massachusetts Male Aging Study Cohort

  2001cited by this paper
• Erratum to: Systemic and cavernous plasma levels of endothelin (1–21) during different penile conditions in healthy males and patients with erectile dysfunction

  2001cited by this paper
• World Wide Web at:

  2001cited by this paper
• Erectile dysfunction.

  2000cited by this paper
• Hypertension is associated with severe erectile dysfunction.

  2000cited by this paper
• Preferences for treatment outcomes in patients with heart failure: symptoms versus survival.

  2000cited by this paper
• The mutually reinforcing triad of depressive symptoms, cardiovascular disease, and erectile dysfunction.

  2000cited by this paper
• Thrombotic thrombocytopenic purpura and clopidogrel--a need for new approaches to drug safety.

  2000cited by this paper
• Erectile dysfunction in general medicine practice: prevalence and clinical correlates

  2000cited by this paper
• Comparison of sexual activity of women and men after a first acute myocardial infarction.

  2000cited by this paper
• The relationship between depression and erectile dysfunction

  2000cited by this paper
• Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk?

  2000cited by this paper
• Cardiac disease, anxiety, and sexual functioning.

  2000cited by this paper
• Indications for penile revascularization and long‐term results

  1999cited by this paper
• Use of sildenafil (Viagra) in patients with cardiovascular disease. Technology and Practice Executive Committee.

  1999cited by this paper
• ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association.

  1999cited by this paper
• ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association.

  1999cited by this paper
• Relationship between psychological profile and cardiological variables in chronic heart failure. The role of patient subjectivity.

  1999cited by this paper
• Depression and heart failure--not yet a target for therapy?

  1999cited by this paper
• The prevalence and etiology of impotence in 101 male hypertensive outpatients.

  1999cited by this paper
• Sexuality of patients with advanced heart failure and their spouses or partners.

  1999cited by this paper
• Efficacy and safety of fluoxetine, sertraline and clomipramine in patients with premature ejaculation: a double-blind, placebo controlled study.

  1998cited by this paper
• A possible mechanism for alteration of human erectile function by digoxin: inhibition of corpus cavernosum sodium/potassium adenosine triphosphatase activity.

  1998cited by this paper
• Long-term followup and selection criteria for penile revascularization in erectile failure.

  1998cited by this paper
• Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group.

  1998cited by this paper
• The Relationship Between Depressive Symptoms and Male Erectile Dysfunction: Cross-Sectional Results From the Massachusetts Male Aging Study

  1998cited by this paper
• Abnormal vascular responses in human chronic cardiac failure are both endothelium dependent and endothelium independent

  1998cited by this paper
• Does severity of ischemic coronary disease correlate with erectile function?

  1997cited by this paper
• [Impotence in diabetic patients: detection of prevalence and social-health implications].

  1997cited by this paper
• Impotencia en pacientes diabéticos: detección de prevalencia e implicaciones sociosanitarias

  1997cited by this paper
• Sexual function in patients with advanced heart failure.

  1996cited by this paper
• Sildenafil, a novel effective oral therapy for male erectile dysfunction.

  1996cited by this paper
• The L-arginine-nitric oxide pathway: role in atherosclerosis and therapeutic implications.

  1996cited by this paper
• Endothelin-1-induced modulation of contractile responses elicited by an alpha 1-adrenergic agonist on human corpus cavernosum smooth muscle.

  1996cited by this paper
• Effects of neoadjuvant androgen deprivation therapy on prostatic cancer.

  1996cited by this paper
• Endothelin-1-induced modulation of contractile responses elicited by an alpha 1-adrenergic agonist on human corpus cavernosum smooth muscle.

  1996cited by this paper
• Endothelium-dependent vasodilatation is not selectively impaired in patients with chronic heart failure secondary to valvular heart disease and congenital heart disease.

  1996cited by this paper
• Reduced gene expression of vascular endothelial NO synthase and cyclooxygenase-1 in heart failure.

  1996cited by this paper
• Prevalence of Self-Reported Erectile Dysfunction in People With Long-Term IDDM

  1996cited by this paper
• Physiology of penile erection.

  1995cited by this paper
• Endothelin-1 as a putative modulator of erectile dysfunction: I. Characteristics of contraction of isolated corporal tissue strips.

  1995cited by this paper
• Endothelin-1 as a putative modulator of erectile dysfunction. II. Calcium mobilization in cultured human corporal smooth muscle cells.

  1995cited by this paper
• Possible role of Na+‐K+‐ATPase in the regulation of human corpus cavernosum smooth muscle contractility by nitric oxide

  1995cited by this paper
• Increased nitric oxide production in heart failure.

  1994cited by this paper
• Control of nitric oxide and prostacyclin synthesis in endothelial cells.

  1994cited by this paper
• Endothelin in human congestive heart failure.

  1994cited by this paper
• [Role of arteriography and percutaneous transluminal angioplasty in the diagnosis and treatment of arterial vasculogenic impotence].

  1994cited by this paper

• Association between cardiovascular drugs and erectile function quality assessed by nocturnal penile tumescence monitoring

  2025cites this paper
• Understanding the erectile dysfunction-cardiovascular disease connection: clinical and pathophysiological insights.

  2025cites this paper
• Poor communication impairs optimal care of patients with heart failure and erectile dysfunction

  2025cites this paper
• Penile erection and cardiovascular function: effects and pathophysiology

  2024cites this paper
• Heart Failure and Erectile Dysfunction: a Review of the Current Evidence and Clinical Implications

  2023cites this paper
• Effect of angiotensin receptor-neprilysin inhibitor treatment on erectile dysfunction in heart failure with a reduced ejection fraction

  2023cites this paper
• Effects of heart failure and coronary artery disease on erectile dysfunction: a two-sample mendelian randomization study

  2023cites this paper
• Sexual function is impaired in women and men with pulmonary hypertension

  2023cites this paper
• Tadalafil treatment improves cardiac, renal and lower urinary tract dysfunctions in rats with heart failure.

  2021cites this paper
• Sexual Dysfunction and Disability

  2021cites this paper
• Sexual Dysfunction Among Patients With Chronic Kidney Disease.

  2021cites this paper
• Cultural adaptation and reliability of the ‘Global Physical Activity Questionnaire’ in patients with heart failure in Greece

  2020cites this paper
• Sexual Activity in Heart Failure Patients: Information Needs and Association with Health-Related Quality of Life

  2019cites this paper
• Sexuální aktivita a kardiovaskulární onemocnění, erektilní dysfunkce jako prediktor ischemické choroby srdeční

  2018cites this paper
• Sexual Dysfunction and Disability

  2018cites this paper
• Sexual Activity in Patients with Cardiac Diseases

  2018cites this paper
• Effects of heart rate reduction with ivabradine on the international ındex of erectile function (IIEF-5) in patients with heart failure

  2018cites this paper
• Mecanismo de Frank Starling: una visión aplicada en la erección del pene

  2018cites this paper
• Percutaneous transluminal coronary angioplasty for acute myocardial infarction: the impact on sexual function in men

  2017cites this paper
• Sexual activity and cardiovascular disease, erectile dysfunction as a predictor of ischemic heart disease

  2017cites this paper
• Effect of prescription medications on erectile dysfunction

  2017cites this paper
• Erectile dysfunction: prevalence, risk factors and involvement of antihypertensive drugs intervention

  2016cites this paper
• Cardiovascular drugs and erectile dysfunction - a symmetry analysis.

  2015cites this paper
• A disfunção eréctil no idoso: marcador de risco cardiovascular

  2015cites this paper
• Erectile Dysfunction in Coronary Artery Disease and Heart Failure

  2015cites this paper
• Erectile Dysfunction and Testosterone

  2015cites this paper
• Sildenafil Improves Erectile Function in Men with Chronic Heart Failure

  2015cites this paper
• ปัจจัยทำนำยกิจกรรมทำงเพศของผู้ป่วยภำวะหัวใจวำย Factors predicting sexual activity among patients with heart failure* บทควำมวิจัย ประภำพร ดองโพธิ์** นรลักขณ์ เอื้อกิจ***

  2014cites this paper
• A interação: Disfunção Eréctil e Doença Cardiovascular

  2014cites this paper
• Sexual Dysfunction Related to Drugs: A Critical Review. Part IV: Cardiovascular Drugs

  2014cites this paper
• Sexual Dysfunction in Heart Failure Patients

  2014cites this paper
• Sexuality of patients with chronic heart failure and their spouses and the need for information regarding sexuality

  2014cites this paper
• ปัจจัยทำนายกิจกรรมทำงเพศของผู้ป่วยภำวะหัวใจวำย Factors predicting sexual activity among patients with heart failure

  2014influential citation
• Sexual Dysfunction Related to Drugs : A Critical

  2014cites this paper
• IMPACTO DE UM PROGRAMA DE REABILITAÇÃO CARDÍACA NA SAÚDE SEXUAL MASCULINA

  2013cites this paper
• A review of the positive and negative effects of cardiovascular drugs on sexual function: a proposed table for use in clinical practice

  2013cites this paper
• Erectile dysfunction in heart failure patients: a critical reappraisal

  2013cites this paper
• Sexual counseling for individuals with cardiovascular disease and their partners: a consensus document from the American Heart Association and the ESC Council on Cardiovascular Nursing and Allied Professions (CCNAP).

  2013cites this paper
• How Can Heart Failure Patients and Their Partners Be Counseled on Sexual Activity?

  2013cites this paper
• The CopenHeartSF trial—comprehensive sexual rehabilitation programme for male patients with implantable cardioverter defibrillator or ischaemic heart disease and impaired sexual function: protocol of a randomised clinical trial

  2013cites this paper
• Managing erectile dysfunction in heart failure.

  2013cites this paper
• Sexual counselling for individuals with cardiovascular disease and their partners: a consensus document from the American Heart Association and the ESC Council on Cardiovascular Nursing and Allied Professions (CCNAP).

  2013cites this paper
• Effectiveness of physical exercise to decrease sexual dysfunction in adults with cardiovascular disease: a systematic review protocol

  2013cites this paper
• Sexual Dysfunction in Men with Systolic Heart Failure and Associated Factors

  2012influential citation
• Quality of life and sexual problems in patients with heart failure

  2012cites this paper
• Sexual dysfunction in males with systolic heart failure and associated factors

  2012cites this paper
• The Role Erectile Dysfunction Plays in Cardiovascular Diseases

  2012cites this paper
• Sexual problems in elderly male and female patients with heart failure

  2012influential citation
• Sexual Activity and Cardiovascular Disease : A Scientific Statement From the American

  2012cites this paper
• Sexual Activity and Cardiovascular Disease : A Scientific Statement From the

  2012cites this paper
• Sexual activity and cardiovascular disease: a scientific statement from the American Heart Association.

  2012cites this paper
• Review: Testosterone Therapy: Treatment of Metabolic Disturbances in Heart Failure

  2011cites this paper
• Effects of Depression on Sexual Activity and Sexual Satisfaction in Heart Failure

  2011cites this paper
• Cardiovascular risk, drugs and erectile function – a systematic analysis

  2011cites this paper
• Erectile Dysfunction as a Complication of Heart Failure

  2010cites this paper
• ORIGINAL RESEARCH—SEXUAL DYSFUNCTION

  2010cites this paper
• The effect of alcohol drinking on erectile dysfunction in Chinese men

  2010cites this paper
• Persistent sexual dysfunction impairs quality of life after cardiac transplantation.

  2010cites this paper
• Erectile dysfunction and its relationship with cardiovascular risk factors and disease.

  2009cites this paper
• Peripheral vascular disease and erectile dysfunction as predictors of mortality in heart failure patients.

  2009cites this paper
• Erectile dysfunction in heart failure: correlation with severity, exercise performance, comorbidities, and heart failure treatment.

  2009cites this paper
• Surveillance of cardiovascular risk factors for outpatients in different erectile dysfunction severity

  2009cites this paper
• Erectile dysfunction and heart failure: the role of phosphodiesterase type 5 inhibitors

  2009cites this paper
• Managing Erectile Dysfunction in Patients With Cardiovascular Diseases: The Efficacy and Safety of Phosphodiesterase-5 Inhibitors

  2009cites this paper
• La disfunción sexual en pacientes en rehabilitación cardiaca es mucho más que un simple «epifenómeno» y debe ser más estudiada

  2008cites this paper
• Sexual dysfunction in cardiac rehabilitation patients is much more than simply an epiphenomenon and needs more study.

  2008cites this paper
• Inverse correlation between testosterone and ventricle ejection fraction, hemodynamics and exercise capacity in heart failure patients with erectile dysfunction.

  2008cites this paper
• Erectile dysfunction.

  2008cites this paper
• The impact of sexual therapy on patients after cardiac events participating in a cardiac rehabilitation program

  2007cites this paper
• Sexual activity and chronic heart failure.

  2007cites this paper
• Sexual dysfunction in the medically ill

  2007influential citation
• The effects of chronic phosphodiesterase-5 inhibitor use on different organ systems

  2007cites this paper
• Sex and the heart

  2006cites this paper
• Sexual activity and cardiovascular disease.

  2003cites this paper